Quantifying the historic contribution of Olympia oysters to filtration in Pacific Coast (USA) estuaries and the implications for restoration objectives

The Olympia oyster, Ostrea lurida Carpenter, was formerly widespread in many US Pacific coast estuaries. Following dramatic declines in the late 1800s and early 1900s, this species is now the focus of renewed restoration efforts. Restoration is undertaken for brood stock rehabilitation as well as a range of ecosystem services such as filtration; however, these ecosystem services are as yet poorly quantified. We present the first laboratory measurements of filtration rates (FR) for O. lurida, to which we fit a model of FR as a function of dry tissue weight and water temperature. We find that O. lurida has a FR at optimum temperature similar to previously established means across oyster species at 1 g dry tissue weight (DTW), but lower than many Crassostrea species. We also find that the allometric exponent relating FR to DTW in O. lurida is lower than the previously published mean across oyster species. Based on our derived filtration rates and historical data, we estimate the historic impact of filtration by O. lurida in five Pacific coast estuaries. We find that historic O. lurida populations did not have the capacity to filter the full volume of the estuary within the estuary residence time in any of the estuaries examined. This result is primarily driven by the low water temperatures and the short estuary residence times that typify the Pacific coast. We conclude that, unlike Crassostrea virginica Gmelin on the Atlantic and Gulf coasts, the Olympia oyster was not historically a dominant force in regulating seston concentrations at large scales in Pacific coast estuaries. Given the differences in the ecological role and habitat structure of these two oyster species, we recommend that analogies between them be drawn with caution. We discuss the implications of our results for developing restoration objectives.     

Proteomic and phosphoproteomic comparison of human ES and iPS cells

Combining high-mass-accuracy mass spectrometry, isobaric tagging and software for multiplexed, large-scale protein quantification, we report deep proteomic coverage of four human embryonic stem cell and four induced pluripotent stem cell lines in biological triplicate. This 24-sample comparison resulted in a very large set of identified proteins and phosphorylation sites in pluripotent cells. The statistical analysis afforded by our approach revealed subtle but reproducible differences in protein expression and protein phosphorylation between embryonic stem cells and induced pluripotent cells. Merging these results with RNA-seq analysis data, we found functionally related differences across each tier of regulation. We also introduce the Stem Cell-Omics Repository (SCOR), a resource to collate and display quantitative information across multiple planes of measurement, including mRNA, protein and post-translational modifications.     

Phosphotyrosine recognition domains: the typical, the atypical and the versatile

Infertility affects one in seven couples globally and has recently been classified as a disease by the World Health Organisation (WHO). While in-vitro fertilisation (IVF) offers effective treatment for many infertile couples, cases exhibiting severe male infertility (19?C57%) often remain difficult, if not impossible to treat. In such cases, intracytoplasmic sperm injection (ICSI), a technique in which a single sperm is microinjected into the oocyte, is implemented. However, 1?C5% of ICSI cycles still fail to fertilise, affecting over 1000 couples per year in the UK alone. Pregnancy and delivery rates for IVF and ICSI rarely exceed 30% and 23% respectively. It is therefore imperative that Assisted Reproductive Technology (ART) protocols are constantly modified by associated research programmes, in order to provide patients with the best chances of conception. Prior to fertilisation, mature oocytes are arrested in the metaphase stage of the second meiotic division (MII), which must be alleviated to allow the cell cycle, and subsequent embryogenesis, to proceed. Alleviation occurs through a series of concurrent events, collectively termed ??oocyte activation??. In mammals, oocytes are activated by a series of intracellular calcium (Ca²⁺) oscillations following gamete fusion. Recent evidence implicates a sperm-specific phospholipase C, PLCzeta (PLC??), introduced into the oocyte following membrane fusion as the factor responsible. This review summarises our current understanding of oocyte activation failure in human males, and describes recent advances in our knowledge linking certain cases of male infertility with defects in PLC?? expression and activity. Systematic literature searches were performed using PubMed and the ISI-Web of Knowledge. Databases compiled by the United Nations and World Health Organisation databases (UNWHO), and the Human Fertilization and Embryology Authority (HFEA) were also scrutinised. It is clear that PLC?? plays a fundamental role in the activation of mammalian oocytes, and that genetic, molecular, or biochemical perturbation of this key enzyme is strongly linked to human infertility where oocyte activation is deficient. Consequently, there is significant scope for our understanding of PLC?? to be translated to the ART clinic, both as a novel therapeutic agent with which to rescue oocyte activation deficiency (OAD), or as a prognostic/diagnostic biomarker of oocyte activation ability in target sperm samples.     

Low density lipoprotein receptor regulation. Kinetic models

The macromolecular species distribution in a receptor-mediated endocytotic pathway was computer simulated based on kinetic data reported in the literature. In the proposed model, the rapidity with which the recycled receptor is shuttled to the cell surface is indicated by the magnitude of k-3, the shuttling constant. The magnitude of k-3 will vary with the experimental conditions, but when this value is large, the internalized receptor is shuttled back to the cell surface with a traverse time of 14 min. Under steady-state conditions, after the cells have been incubated in the presence of LDL for 5 h (M.S. Brown and J.L. Goldstein, Cell 9 (1976) 663), the time required for a receptor to traverse the entire endocytotic pathway is 52 min. Our simulation suggests that normal LDL binding in such a short-term experiment may be independent of receptor synthesis. Thus, the degradation of LDL and resultant build-up of cholesterol would have no apparent inhibitory effect on the down-regulation of receptor synthesis.